Cargando…
Azilsartan/chlorthalidone combination therapy for blood pressure control
BACKGROUND: Edarbyclor(®) is a combined angiotensin receptor blocker (ARB) and thiazide-like diuretic (azilsartan and chlorthalidone), and was approved on December 20, 2011 by the US Food and Drug Administration (FDA) for hypertension management. OBJECTIVE: To review the pharmacology, pharmacokineti...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685454/ https://www.ncbi.nlm.nih.gov/pubmed/23807859 http://dx.doi.org/10.2147/IBPC.S34792 |